Recognizing and Managing Malignant Hyperthermia in the ICU
Malignant hyperthermia (MH) is a rare but potentially fatal complication triggered by inhalational anesthetics and succinylcholine in genetically susceptible ICU patients. This expert-led review by Sheila Riazi, Teeda Pinyavat, and Jia Wen Deng provides essential guidance on recognizing and managing MH in critical care. Learn how to identify symptoms early and implement life-saving treatment protocols in the ICU.
An expert review highlights the urgent need for greater awareness of malignant hyperthermia (MH)—a rare but life-threatening reaction to inhalational anesthetics and succinylcholine in genetically susceptible patients in critically ill patients. This narrative review led by malignant hyperthermia experts Sheila Riazi (Toronto Western Hospital – University Health Network, Canada), Teeda Pinyavat (Columbia University, New York), and medical student Jia Wen Deng (University of Toronto) provide a practical guide on recognizing and treating this serious hypermetabolic condition.
To read the Article : https://journals.lww.com/ccmjournal/abstract/2024/12000/malignant_hyperthermia.14.aspx
